Drug profile · INN
prednisone
PANAFCORT
prednisone (PANAFCORT) is a glucocorticoid receptor agonist. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — prednisone
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 4
- Programs
- 102
- Data quality
- 0.89
Quick answer
prednisone (PANAFCORT) is a glucocorticoid receptor agonist. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Recent coverage
FDA Approves Capivasertib for PTEN-Deficient Prostate Cancer
FDA Approves Capivasertib for PTEN-Deficient prostate cancer, expanding TRUQAP into a new oncology setting. The approval pairs capivasertib with abiraterone and prednisone for adults with PTEN-deficient metastatic androgen pathway modulation-naive or sensitive disease.
FDA approves capivasertib plus abiraterone and prednisone in PTEN-deficient mHSPC
The FDA approved capivasertib plus abiraterone and prednisone for adult patients with PTEN-deficient metastatic androgen pathway modulation-naïve or sensitive prostate cancer. The move creates a new catalyst for AstraZeneca’s Truqap and adds a biomarker-defined prostate cancer use to track.
Truqap gains US approval in PTEN-deficient metastatic prostate cancer
AstraZeneca’s Truqap (capivasertib) has been approved in the US with abiraterone and prednisone for PTEN-deficient metastatic prostate cancer. The move creates a first-in-class targeted option and a new catalyst to watch for BD teams, investors, and analysts.
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is prednisone?
prednisone (PANAFCORT) is a glucocorticoid receptor agonist. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for prednisone?
PANAFCORT is a marketed brand name for prednisone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of prednisone?
prednisone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.